EMA Post-Brexit: 'It Can’t Stay In The UK' … Or Can It?
The assumption to date has been that the European Medicines Agency will have to move from its London base when the UK leaves the EU. But things may not be quite that simple.
You may also be interested in...
The European Medicines Agency is important to the UK but the government cannot say it will be a non-negotiable point in future talks regarding the country’s departure from the EU.
It's fair to say that the outcome of the June 23, 2016 referendum on the UK’s membership of the EU stunned not only the nation, whether you voted to leave or remain, but sent shockwaves through Europe and beyond. The UK’s pharmaceutical industry made no secret of its stance: it was all about remain – but it got a Brexit. Scrip’s Sukaina Virji gathered a group of pharma industry experts who had spent their summer working on making the best of the situation. Here’s an edited recount of their insightful discussion.
Ireland’s health minister says the country is preparing to launch a formal bid to host the European Medicines Agency following the UK’s decision to quit the EU, claiming it can offer an “excellent track record” in regulating medicines and medical devices, a proactive drugs agency, and a “thriving” pharmaceutical sector.